Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity-Reference-Cited by-同舟云学术

Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity

Published:2005-10-01 Issue:2 Volume:65 Page:151-158
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Hatziapostolou Maria,Delbe Jean,Katsoris Panagiotis,Polytarchou Christos,Courty Jose,Papadimitriou Evangelia

Publisher

Wiley

Subject

Urology,Oncology

Reference34 articles.

1. The molecular biology, endocrinology and physiology of the prostate and seminal vesicles. In: , , , editors. Campbell's urology, 6th edn. Philadelphia: Saunders, Inc.; 1992. pp 221-251.

2. Growth factor involvement in progression of prostate cancer

3. Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?

4. Endothelial Cell Proliferation Induced by HARP: Implication of N or C Terminal Peptides

5. Pleiotrophin induces angiogenesis: Involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Binding of pleiotrophin to cell surface nucleolin mediates prostate cancer cell adhesion to osteoblasts;Tissue and Cell;2022-06

2. Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer;British Journal of Cancer;2020-12-08

3. Pleiotrophin: Activity and mechanism;Advances in Clinical Chemistry;2020

4. Pleiotrophin, a multifunctional cytokine and growth factor, induces leukocyte responses through the integrin Mac-1;Journal of Biological Chemistry;2017-11

5. A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer’s disease;Scientific Reports;2017-10-17